Sponsor

Synteract, Inc.

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Synteract, Inc. appears in 5 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials5
Recruiting shown0
Roles1
SourceClinicalTrials.gov
Advertisement

Clinical trials

5 shown
MTG201 Plus Nivolumab in Patients With Relapsed Pleural MesotheliomaNCT04013334 · collaborator · 2019-08-15
UNKNOWN
Open-Label Study to Evaluate the Long-Term Safety and Efficacy of VI-0521 in Type 2 Diabetic AdultsNCT00737633 · collaborator · 2008-08-01
TERMINATED
A VI-0521 Study to Evaluate the Long-term Safety and Efficacy in Type 2 Diabetic AdultsNCT00600067 · collaborator · 2008-01-01
COMPLETED
Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese DiabeticsNCT00486291 · collaborator · 2007-06-01
COMPLETED
A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.NCT00432562 · collaborator · 2007-02-01
COMPLETED

Sponsor roles

collaborator5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.